Trial Profile
A phase Ia trial of Recombinant Human HGF for Treatment of Renal Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2016
Price :
$35
*
At a glance
- Drugs Hepatocyte growth factor (Primary)
- Indications Renal failure
- Focus Adverse reactions; Pharmacokinetics
- 09 Mar 2016 New trial record